Lexicon Pharma (LXRX), Ipsen Enter Licensing Agreemen for Telotristat Etiprate Outside N.A., Japan
Tweet Send to a Friend
Ipsen and Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced that they have entered into an exclusive licensing agreement for Ipsen to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
